Mundipharma extends partnership with NTC for licensing and distribution rights for ophthalmology portfolio into Latin America

  • Jul 25, 2018

Mexico City, 25 July 2018: Mundipharma has expanded its ophthalmology portfolio in Latin America by agreeing a new commercial partnership with NTC – an Italian pharmaceutical company with deep experience in research and development – for exclusive rights to license and distribute a range of ophthalmic medicines across the region...

NTC to strengthen its ophthalmology portfolio through the acquisition of ocular antibiotic products

  • May 31, 2018

The company anticipates the next opening of a branch in Spain, with a broad portfolio of quality products. 

NTC at CPhI - Madrid 2018

  • May 28, 2018

CPhI Worldwide, 9 - 11 October 2018.
See you in Madrid. #cphi.com

NTC Pharma organized Leader7 Investigators’ Meeting

  • May 12, 2018

In Milan, on May 12, NTC Pharma organised Leader7 Investigators’ Meeting with 90 ophthalmologists representing 57 Italian centers, OPIS Group team and NTC people involved in this clinical research project, one of the widest multicentre clinical studies conducted in Europe in Ophthalmology. NTC is strongly committed in the fight against antibiotic resistance as demonstrated by this study and other initiatives that are building the path of NTC to the Next Level.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. READ MORE